Since the Data Protection Law (“Lei Geral de Proteção de Dados” – “LGPD”) entered into force, a lot has been said on the regulatory uncertainties that orbit the universe of regulation of the subject in micro-enterprises, small businesses, and startups. Among the several uncertainties, one in special has taken the sleep of most entrepreneurs: the obligation to appoint a DPO (Data Protection Officer, as provided by the European Union General Data Protection Regulation).
Autorização para os registros veio com a publicação, nesta semana, da Portaria nº 37.
This Tuesday, September 21, 2021, the Brazilian Patent and Trademark Office (BPTO) published a new ordinance that regulates position marks in Brazil.
Recentemente o INPI -Instituto Nacional de Propriedade Industrial compartilhou uma Consulta Pública sobre o exame de pedidos de registro de Marcas de Posição (Consulta Pública 01/2021), possibilitando a manifestação de interessados no tema.
União incorreria em grave ilegalidade ao não assegurar recursos financeiros à autarquia e ficar com parte do que ela arrecada.
The National Institute of Industrial Property (INPI) recently carried out a public consultation on the examination of applications for the registration of position marks, enabling interested parties to express their opinions on the matter.
Over the past five years, the Brazilian Patent and Trademark Office (BPTO) has adopted various measures to reduce the backlog in patent examinations and implemented several improvements in its examination guidelines to enable high-quality technical examinations to be performed. In addition, the covid-19 pandemic has led to other sensitive discussions regarding the Brazilian patent system and its impact on public health issues. This article provides an overview of six topics that directly affect life sciences patents in Brazil.
Por se tratar de um mercado extremamente inovador e em constante evolução, a Propriedade Intelectual é um dos ramos do direito que a Indústria dos Games não pode dispensar.
On September 02, Bill no. 12/21 was sanctioned in Brazil, aiming to amend the provisions of compulsory licenses set forth by the Brazilian IP Law in cases of national or international emergency, and in case of public interest or recognition of public calamity nationwide, as well.
Sancionada na semana passada, a lei que elimina a exigência de autorização prévia da Agência Nacional de Vigilância Sanitária (Anvisa) para pedidos de patente de produtos farmacêuticos vai acelerar a tramitação de 1.134 processos.